The study , presented as a poster during the 69th Annual Scientific Sessions of the American Diabetes Association ( ADA ) , found that among patients 65 or younger , there was no significant difference between Lantus ( R ) and NPH in A1C reduction ( 1.26 % for Lantus ( R ) , 1.20 % for NPH ) or fasting blood glucose ( FBG ) reduction ( 86 mg / dL for Lantus ( R ) , 84 mg / dL for NPH ) after 24 weeks of treatment .